Fang H - Search Results

1

Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors.

Jiao J, Fang H, Wang X, Guan P, Yuan Y, Xu W. Jiao J, et al. Among authors: fang h. Eur J Med Chem. 2009 Nov;44(11):4470-6. doi: 10.1016/j.ejmech.2009.06.010. Epub 2009 Jun 17. Eur J Med Chem. 2009. PMID: 19608304

2

Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as alpha(1)-adrenoceptor antagonists.

Li MY, Fang H, Xia L. Li MY, et al. Among authors: fang h. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3216-9. doi: 10.1016/j.bmcl.2005.05.003. Bioorg Med Chem Lett. 2005. PMID: 15935663

3

Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors.

Zhang L, Zhang J, Fang H, Wang Q, Xu W. Zhang L, et al. Among authors: fang h. Bioorg Med Chem. 2006 Dec 15;14(24):8286-94. doi: 10.1016/j.bmc.2006.09.015. Epub 2006 Sep 27. Bioorg Med Chem. 2006. PMID: 17008101

4

Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.

Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Zhang J, et al. Among authors: fang h. Bioorg Med Chem. 2007 Apr 1;15(7):2749-58. doi: 10.1016/j.bmc.2007.01.020. Epub 2007 Jan 19. Bioorg Med Chem. 2007. PMID: 17287121

5

Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.

Li Q, Fang H, Xu W. Li Q, et al. Among authors: fang h. Bioorg Med Chem Lett. 2007 May 15;17(10):2935-8. doi: 10.1016/j.bmcl.2006.12.095. Epub 2007 Jan 5. Bioorg Med Chem Lett. 2007. PMID: 17433673

6

Recent advance in the research of flavonoids as anticancer agents.

Li Y, Fang H, Xu W. Li Y, et al. Among authors: fang h. Mini Rev Med Chem. 2007 Jul;7(7):663-78. doi: 10.2174/138955707781024463. Mini Rev Med Chem. 2007. PMID: 17627579 Review.

7

Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors.

Liu FZ, Fang H, Zhu HW, Wang Q, Yang Y, Xu WF. Liu FZ, et al. Among authors: fang h. Bioorg Med Chem. 2008 Jan 1;16(1):578-85. doi: 10.1016/j.bmc.2007.04.030. Epub 2007 Apr 25. Bioorg Med Chem. 2008. PMID: 17937988

8

Role of sulfonamide group in matrix metalloproteinase inhibitors.

Cheng XC, Wang Q, Fang H, Xu WF. Cheng XC, et al. Among authors: fang h. Curr Med Chem. 2008;15(4):368-73. doi: 10.2174/092986708783497300. Curr Med Chem. 2008. PMID: 18288991 Review.

9

Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.

Cheng XC, Wang Q, Fang H, Xu WF. Cheng XC, et al. Among authors: fang h. Curr Med Chem. 2008;15(4):374-85. Curr Med Chem. 2008. PMID: 18288992 Review.

10

Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.

Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Zhang J, et al. Among authors: fang h. Bioorg Med Chem. 2008 Apr 1;16(7):3839-47. doi: 10.1016/j.bmc.2008.01.036. Epub 2008 Jan 30. Bioorg Med Chem. 2008. PMID: 18304821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,520 results

Search Page

Filters